190 related articles for article (PubMed ID: 19461125)
1. Prediction of HLA-DQ8beta cell peptidome using a computational program and its relationship to autoreactive T cells.
Chang KY; Unanue ER
Int Immunol; 2009 Jun; 21(6):705-13. PubMed ID: 19461125
[TBL] [Abstract][Full Text] [Related]
2. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
[TBL] [Abstract][Full Text] [Related]
3. Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.
Ge X; James EA; Reijonen H; Kwok WW
J Autoimmun; 2011 Mar; 36(2):155-60. PubMed ID: 21257290
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.
van Lummel M; van Veelen PA; de Ru AH; Pool J; Nikolic T; Laban S; Joosten A; Drijfhout JW; Gómez-Touriño I; Arif S; Aanstoot HJ; Peakman M; Roep BO
Diabetes; 2016 Mar; 65(3):732-41. PubMed ID: 26718497
[TBL] [Abstract][Full Text] [Related]
5. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes.
Kelemen K; Gottlieb PA; Putnam AL; Davidson HW; Wegmann DR; Hutton JC
J Immunol; 2004 Mar; 172(6):3955-62. PubMed ID: 15004204
[TBL] [Abstract][Full Text] [Related]
6. Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.
Lombardi A; Concepcion E; Hou H; Arib H; Mezei M; Osman R; Tomer Y
J Autoimmun; 2020 Dec; 115():102543. PubMed ID: 32951964
[TBL] [Abstract][Full Text] [Related]
7. HLA-DQ8 transgenic and NOD mice recognize different epitopes within the cytoplasmic region of the tyrosine phosphatase-like molecule, IA-2.
Kudva YC; Deng YJ; Govindarajan R; Abraham RS; Marietta EV; Notkins AL; David CS
Hum Immunol; 2001 Oct; 62(10):1099-105. PubMed ID: 11600216
[TBL] [Abstract][Full Text] [Related]
8. Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif.
Herman AE; Tisch RM; Patel SD; Parry SL; Olson J; Noble JA; Cope AP; Cox B; Congia M; McDevitt2 HO
J Immunol; 1999 Dec; 163(11):6275-82. PubMed ID: 10570321
[TBL] [Abstract][Full Text] [Related]
9. Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.
Wen L; Wong FS; Burkly L; Altieri M; Mamalaki C; Kioussis D; Flavell RA; Sherwin RS
J Clin Invest; 1998 Sep; 102(5):947-57. PubMed ID: 9727063
[TBL] [Abstract][Full Text] [Related]
10. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice.
Boyton RJ; Lohmann T; Londei M; Kalbacher H; Halder T; Frater AJ; Douek DC; Leslie DG; Flavell RA; Altmann DM
Int Immunol; 1998 Dec; 10(12):1765-76. PubMed ID: 9885897
[TBL] [Abstract][Full Text] [Related]
11. Type 1 diabetes induction in humanized mice.
Tan S; Li Y; Xia J; Jin CH; Hu Z; Duinkerken G; Li Y; Khosravi Maharlooei M; Chavez E; Nauman G; Danzl N; Nakayama M; Roep BO; Sykes M; Yang YG
Proc Natl Acad Sci U S A; 2017 Oct; 114(41):10954-10959. PubMed ID: 28874533
[TBL] [Abstract][Full Text] [Related]
12. T cell receptor recognition of hybrid insulin peptides bound to HLA-DQ8.
Tran MT; Faridi P; Lim JJ; Ting YT; Onwukwe G; Bhattacharjee P; Jones CM; Tresoldi E; Cameron FJ; La Gruta NL; Purcell AW; Mannering SI; Rossjohn J; Reid HH
Nat Commun; 2021 Aug; 12(1):5110. PubMed ID: 34433824
[TBL] [Abstract][Full Text] [Related]
13. NOD background genes influence T cell responses to GAD 65 in HLA-DQ8 transgenic mice.
Abraham RS; Wilson SB; de Souza NF; Strominger JL; Munn SR; David CS
Hum Immunol; 1999 Jul; 60(7):583-90. PubMed ID: 10426275
[TBL] [Abstract][Full Text] [Related]
14. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.
Suri A; Walters JJ; Gross ML; Unanue ER
J Clin Invest; 2005 Aug; 115(8):2268-76. PubMed ID: 16075062
[TBL] [Abstract][Full Text] [Related]
15. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model.
Wen L; Chen NY; Tang J; Sherwin R; Wong FS
J Clin Invest; 2001 Apr; 107(7):871-80. PubMed ID: 11285306
[TBL] [Abstract][Full Text] [Related]
16. First signature of islet beta-cell-derived naturally processed peptides selected by diabetogenic class II MHC molecules.
Suri A; Walters JJ; Rohrs HW; Gross ML; Unanue ER
J Immunol; 2008 Mar; 180(6):3849-56. PubMed ID: 18322192
[TBL] [Abstract][Full Text] [Related]
17. Expression of the B7.1 costimulatory molecule on pancreatic beta cells abrogates the requirement for CD4 T cells in the development of type 1 diabetes.
Havari E; Lennon-Dumenil AM; Klein L; Neely D; Taylor JA; McInerney MF; Wucherpfennig KW; Lipes MA
J Immunol; 2004 Jul; 173(2):787-96. PubMed ID: 15240665
[TBL] [Abstract][Full Text] [Related]
18. Modulatory role of DR4- to DQ8-restricted CD4 T-cell responses and type 1 diabetes susceptibility.
Ge X; Piganelli JD; Tse HM; Bertera S; Mathews CE; Trucco M; Wen L; Rudert WA
Diabetes; 2006 Dec; 55(12):3455-62. PubMed ID: 17130492
[TBL] [Abstract][Full Text] [Related]
19. A molecule's right to choose: how diabetogenic class II MHC products bind peptides.
Ploegh HL
J Clin Invest; 2005 Aug; 115(8):2077-9. PubMed ID: 16075053
[TBL] [Abstract][Full Text] [Related]
20. Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes.
Harfouch-Hammoud E; Walk T; Otto H; Jung G; Bach JF; van Endert PM; Caillat-Zucman S
Diabetes; 1999 Oct; 48(10):1937-47. PubMed ID: 10512357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
